Allergan to Acquire Elastagen to Access Next Generation Injectable Portfolio

  Allergan to Acquire Elastagen to Access Next Generation Injectable Portfolio   • Clinical stage tropoelastin platform with potential applications in aesthetics, scar remodeling and surgical wound repair • Introduces key ‘youth protein’ tropoelastin to Allergan’s Juvederm dermal filler portfolio • Provides infrastructure for further development and following approval to commercialize Elastagen’s products   SYDNEY…

Details